Dr Susana Banerjee
Consultant Medical Oncologist, Clinical Research Lead Gynaecology Unit MBBS MA PhD FRCP
Available at: Chelsea, Sutton
- ovarian, advanced endometrial and cervical cancer
- chemotherapy, targeted therapy
- clinical trials
- BRCA ovarian cancer
Dr Susana Banerjee is a Consultant Medical Oncologist and Research Lead for the Gynaecology Unit. She is a Team Leader in Gynaecological Cancers at the Institute of Cancer Research. Dr Banerjee specialises in ovarian cancer and the systemic treatment of endometrial and cervical cancers.
Dr Banerjee graduated with a first class degree from St John’s College, University of Cambridge, and completed her medical training at Royal Free Medical School where she was a University of London Gold Medal finalist. Dr Banerjee was awarded an Avon Breast Cancer Crusade Clinical Fellowship for laboratory research and gained a PhD from The Institute of Cancer Research, University of London. Dr Banerjee was awarded the San Antonio Breast Cancer Symposium Novartis Oncology Basic Science Award for her research in 2007. Other prizes include the Association of Cancer Physicians McElwain Prize and the Sir Antony Driver Prize. She was also highly commended for the Pfizer British Oncology Association Young Investigator Award. She completed specialist training at The Royal Marsden.
Dr Banerjee has been involved in several national and international specialist groups including the National Cancer Research Institute (NCRI) Gynaecological Cancers Clinical Studies Group, European Organization for Research and Treatment of Cancer (EORTC) Executive Steering Committee for Gynaecological Cancers, and ESGO (European Society of Gynaecological Oncology) Congress Faculty. Dr Susana Banerjee serves on the European Society of Medical Oncology (ESMO) Executive Board and Women for Oncology Committee. She is Track Chair for Gynaecological Cancers for the ESMO Congress 2018 and Scientific Co-Chair for ESMO Asia 2018.
Dr Banerjee is an author of over 80 peer-reviewed publications and is actively involved in clinical trials and translational research. Her research interests include individualisation of patient treatment and targeted therapies in gynaecological cancers. Dr Banerjee is UK Chief Investigator and principal investigator at The Royal Marsden for multiple national and international clinical trials. Dr Banerjee is a member of the advisory board for the international journal Nature Reviews Clinical Oncology and editorial board of Cancer Treatment Reviews and International Journal of Gynecological Cancer.